SCHEMBL29270726

SCHEMBL29270726

Cc1cc2c(cc1C(=O)NN)N(Cc1ccc(Cl)cc1)C(=O)[C@@H](CC(C)(C)NC(=O)O)CS2

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TP53 P04637 3/20 0.37
▸ MAPT P10636 5/20 0.37
▸ SMN1; SMN2 Q16637 3/20 0.37
▸ LMNA P02545 2/20 0.37
▸ POLB P06746 1/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.33
▸ HDAC1 Q13547 3/20 0.33
▸ HDAC8 Q9BY41 3/20 0.33
▸ HDAC6 Q9UBN7 3/20 0.33
▸ PRKAG1 P54619 1/20 0.33
▸ PRKAA2 P54646 1/20 0.33
▸ PRKAB1 Q9Y478 1/20 0.33
▸ CLK1 P49759 1/20 0.33
▸ HDAC3 O15379 1/20 0.32
▸ HDAC4 P56524 1/20 0.32
▸ HDAC7 Q8WUI4 1/20 0.32
▸ HDAC2 Q92769 1/20 0.32
▸ HDAC10 Q969S8 1/20 0.32
▸ HDAC11 Q96DB2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29270772 0.92 TP53 (0.35) TP53MAPTSMN1; SMN2LMNAPOLB
SCHEMBL29270847 0.89 TP53 (0.47) TP53MAPTSMN1; SMN2LMNANPC1
SCHEMBL29270781 0.85 TP53 (0.37) TP53MAPTSMN1; SMN2LMNAPOLB
SCHEMBL29270816 0.85 MAPT (0.33) TP53MAPTSMN1; SMN2LMNAPOLB
SCHEMBL29270810 0.82 TP53 (0.35) TP53MAPTSMN1; SMN2LMNAPOLB
SCHEMBL29270690 0.82 ALDH1A1 (0.41) TP53MAPTSMN1; SMN2LMNANPC1
SCHEMBL29270744 0.81 TP53 (0.34) TP53MAPTSMN1; SMN2LMNAALDH1A1
SCHEMBL29270701 0.80 CNR2 (0.32) —
SCHEMBL29270828 0.80 TP53 (0.34) TP53MAPTSMN1; SMN2LMNAALDH1A1
SCHEMBL26961771 0.79 MAPT (0.41) TP53MAPTSMN1; SMN2LMNAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116964048-A Bicyclic tetrahydroazepine derivatives for the treatment of cancer 豪夫迈·罗氏有限公司 2023-10-27 — — CN disclosed
Send feedback